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MicelleFXYD1 (phospholemman) is a member of an evolutionarily conserved family of membrane proteins that
regulate the function of the Na,K-ATPase enzyme complex in speciﬁc tissues and speciﬁc physiological states.
In heart and skeletal muscle sarcolemma, FXYD1 is also the principal substrate of hormone-regulated
phosphorylation by c-AMP dependent protein kinase A and by protein kinase C, which phosphorylate the
protein at conserved Ser residues in its cytoplasmic domain, altering its Na,K-ATPase regulatory activity.
FXYD1 adopts an L-shaped α-helical structure with the transmembrane helix loosely connected to a
cytoplasmic amphipathic helix that rests on the membrane surface. In this paper we describe NMR expe-
riments showing that neither PKA phosphorylation at Ser68 nor the physiologically relevant phosphorylation
mimicking mutation Ser68Asp induces major changes in the protein conformation. The results, viewed in
light of a model of FXYD1 associated with the Na,K-ATPase α and β subunits, indicate that the effects of
phosphorylation on the Na,K-ATPase regulatory activity of FXYD1 could be due primarily to changes in
electrostatic potential near the membrane surface and near the Na+/K+ ion binding site of the Na,K-ATPase
α subunit.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The FXYD proteins constitute a family of regulatory subunits of the
Na,K-ATPase ion pump, the principal enzyme responsible for main-
taining the gradient of Na+ and K+ ion concentrations across cell
membranes [1–3]. The enzyme complex is formed by a catalytic α
subunit (110 kDa), an auxiliary β subunit (31–kDa), and a regulatory
FXYD subunit (7–17 kDa). The known isoforms of the three subunits,
α1-α4, β1-β3, and FXYD1-FXYD10, show a high level of subunit-
speciﬁc sequence similarity and their expression is tissue-speciﬁc as
well as developmentally regulated [4,5]. The energy required to ex-
change 3 Na+ ions for 2 K+ ions across the plasma membrane is
generated by the hydrolysis of ATP in the cytosol, through a process
involving distinct intermediate states of the enzyme that is regulated
by the FXYD proteins.
The FXYD family proteins have been reported to induce distinct,
and sometimes opposing, effects on the enzyme's rate constant and on
its afﬁnity for intracellular Na+ or extracellular K+ ions [1–3]. These
differences have been ascribed to speciﬁc differences in the amino
acid sequences of the FXYD transmembrane domains, which are
otherwise highly conserved throughout the protein family, and to
differences in the cytoplasmic domains, whose sequences vary widely
among the FXYD family members. The FXYD structures mirror the+1 858 713 6268.
i).
ll rights reserved.intron–exon arrangements of their corresponding genes, suggesting
that the polypeptides are assembled from discrete structured domains
that may have evolved to confer different functional properties in
various physiological settings [6]. The FXYD activities are also modu-
lated by post-translational modiﬁcations, including phosphorylation
(FXYD1) and glycosylation (FXYD5). For example, in heart and ske-
letal muscle, FXYD1 (PLM; phospholemman) is the principal substrate
of hormone-stimulated phosphorylation by c-AMP dependent protein
kinase A (PKA) and protein kinase C (PKC), which speciﬁcally phos-
phorylate the protein either at Ser68 (PKA), or at Ser63, Ser68 and
Thr69 (PKC) in its cytoplasmic domain [7–9]. Functional studies in
cells indicate that phosphorylation of FXYD1 can inﬂuence the protein
activity in at least two ways: either indirectly, by regulating the level
of FXYD1 expression at the plasma membrane, or directly, by altering
the functional properties of FXYD1 associatedwith the Na,K-ATPase at
the plasma membrane [9,10].
Phosphorylation of FXYD1 is a key factor regulating the delivery of
FXYD1 from the endoplasmic reticulum (ER) to the plasmamembrane
[9]. The last three arginines at the C-terminus of FXYD1 resemble the
RXR motif implicated in the ER retention of multimeric membrane
proteins (reviewed in [11]). Notably, the ER-retention sequence of
one such protein, the NR1 subunit of the NMDA receptor, is regulated
by coordinated PKA/PKC phosphorylation at speciﬁc sites in its vici-
nity [12]; phosphorylation is thought to screen the positively charged
ER-retention signal and, thus, enable the NR1 subunit to trafﬁc from
the ER. PKA phosphorylation of NR1 appears to be constitutive in all
secretory compartments and to be required for efﬁcient PKC
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the ER it is rapidly dephosphorylated at PKC sites. Interestingly, the
amount of FXYD1 expressed in oocyte membranes is increased by
co-expression of PKA [13]. Furthermore, the pattern of PKA/PKC
phosphorylation in the C-terminus of FXYD1 resembles that of the
NMDA NR1 ER-retention sequence (Fig. 1), suggesting that a similar
mechanism may operate to regulate FXYD1 export from the ER to the
plasma membrane. Further underscoring the importance of the
indirect effects of phosphorylation on pump activity, PKA/PKC
phosphorylation of the Na,K-ATPase α subunit has also been shown
to regulate trafﬁcking of the pump from intracellular organelles to the
plasma membrane, thereby affecting the pump expression level and
activity [14].
FXYD1 phosphorylation has also been reported to relieve FXYD1
inhibition of the Na,K-ATPase through the direct functional
interaction of FXYD1 with the pump [10,15–19]. Speciﬁcally, the
co-expression of FXYD1 with α1/β1 or α2/β1 isozymes in oocytes
or in HeLa cells causes a signiﬁcant decrease in the afﬁnity of the
Na,K-ATPase for Na+ ions, with a smaller decrease in their afﬁnity
for K+ ions and little effect on the transport rate [20,21], and both
α1, which is found in nearly all animal tissues, and α2, which is
highly expressed in heart and skeletal muscle, are speciﬁcally
stabilized by FXYD1 [22]. PKA phosphorylation of FXYD1 reverses
these effects, increasing the apparent Na+ afﬁnity of both α1/β1
and α2/β1 isozymes, with no effect on their apparent K+ afﬁnity
nor on their maximal transport activity, whereas PKC phosphory-
lation selectively increases the maximal pump current of the α2/β1
but not α1/β1 isozyme [10]. These effects of phosphorylated FXYD1
(pFXYD1) on Na,K-ATPase activity are recapitulated in a mutant
form of FXYD1 where Ser63 and Ser68 were changed to Asp to
mimic the effects of phosphorylation [10]. Finally, in cardiac myo-
cytes isolated from FXYD1 knockout mice, the Na,K-ATPase activity
was increased signiﬁcantly [15,17,18,23], indicating that FXYD1 plays
an important role in heart contractile function. In contrast, over-
expression of FXYD1 in wild-type myocytes reduced Na,K-ATPase
activity [24], while FXYD1 phosphorylation by PKA and PKC increased
it [15–19].
The direct effects of FXYD1 phosphorylation on Na,K-ATPase
activity have been proposed to reﬂect a major change in the con-
formation of FXYD1, however, no structural information has been
available for the phosphorylated protein and the nature of the con-
formational change is not known. In this paper we report the effects of
PKA phosphorylation on the three-dimensional structure of FXYD1
examined by NMR spectroscopy.
Two crystal structures of the Na,K-ATPase were recently reported,
one determined at 3.5 Å resolution for the α1/β1/FXYD2 complex
isolated from pig kidney [25], and the other determined at 2.4 Å
resolution for the α3/β1/FXYD10 complex isolated from shark rectal
glands [26]. In both structures, the pump is in the E2 occluded ion
conformation and is in complex with occluded Rb+ ions acting asFig. 1. Amino acid sequence and secondary structure of human FXYD1 (NCBI: NP_068702) an
full length FXYD1. The S63, S68, T69 phosphorylation sites are marked with arrows. Ac
Phosphorylation domains of FXYD1 and NMDA NR1. Arrows mark the PKA and PKC phosphsubstitutes for the K+ ions that would be found in vivo. The structures
identify the arrangement of the cytoplasmic domain and ten trans-
membrane helices of the α subunit, and show that the β subunit
transmembrane helix associates with transmembrane helices αM7
and αM10, while the FXYD protein transmembrane helix associates
with transmembrane helix αM9. However, no structural information
could be obtained for the β and FXYD cytoplasmic domains due to lack
of electron density.
Recently, we determined the NMR structure of non-phosphory-
lated FXYD1 in detergent micelles [27]. The N-terminal transmem-
brane domain forms three rigidly connected helices (h1, h2, h3) and
shares both signiﬁcant amino acid sequence homology [5] as well as
structural similarity [6,28] with the other FXYD proteins (Fig. 1). It is
loosely connected to a 10-residue C-terminal cytoplasmic helix (h4)
with a sequence unique to FXYD1, which contains the phosphoryla-
tion domain. Helix h4 is ﬂanked by an N-terminal acidic sequence
(DEEE) and a C-terminal basic ER-retention sequence (RRR) that are
important for mediating trafﬁcking from the ER [9], and rests on the
membrane surface exposing the phosphorylation sites (Ser63, Ser68
and Thr69) to the aqueous phase. This helix is highly basic, which
helps explain its propensity to associate with a negatively charged
micelle/membrane surface, however, it is connected to the rest of the
protein by a relatively long ﬂexible linker, indicating that it would be
capable of adopting a different orientation in its interaction with the
Na,K-ATPase α subunit and of undergoing reorientation upon
phosphorylation.
We ﬁnd that neither phosphorylation at Ser68 nor the Ser68Asp
mutation mimicking PKA phosphorylation cause major changes in
protein conformation, and that both appear to induce only a modest
increase in the mobility of the cytoplasmic helix. Together with a
model of FXYD1 bound to the Na,K-ATPase α subunit, the NMR
results indicate that the effects of phosphorylation on the Na,K-
ATPase regulatory activity of FXYD1 could be due primarily to the
localization and movement of charged residues at the membrane
surface and, possibly, near the Na+/K+ ion binding sites of the
pump.
2. Materials and methods
2.1. Sample preparation
Uniformly 15N-labeled FXYD1 and FXYD1(S68D) were expressed,
puriﬁed, and characterized as described previously [29]. The Ser68Asp
mutation was generated using the QuickChange mutagenesis kit
(Stratagene) and veriﬁed by DNA sequencing. Puriﬁed FXYD1 was
phosphorylated with PKA by dissolving 1 mg of protein in 2 mL of
buffer A (50mMHEPES, pH 5; 25mMMgCl2, 25 mMNaF, 1 mM EGTA,
0.1% triton X-100, 1 mM ATP), adding 20 μg of PKA, and gently mixing
for 5 h at 30 °C. To stop the reaction, PKA was inactivated by adding
SDS to a ﬁnal concentration of 4 mM. pFXYD1 was isolated from thed comparisonwith human NMDA receptor NR1 subunit (NCBI: NP_015566). (A) Mature
idic (DEEE) and basic (RRR) sequences important for ER export are underlined. (B)
orylation sites. The ER-retention signals (RRR) are underlined.
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Amersham) in buffer B (10 mM sodium phosphate, pH 7.5, 12 mM
DTT, 4 mM SDS). The fractions containing pFXYD1 were pooled and
concentrated to 1 mL in a stirred cell (Amicon) with a dialysis mem-
brane of 5 kDa molecular weight cutoff. After a brief (5 h) dialysis
against water, the resulting solution was lyophilized and stored at
−20 °C.
Previous analysis with an antibody speciﬁc for Ser68-phosphory-
lated FXYD1 demonstrated that this procedure phosphorylates FXYD1
speciﬁcally at Ser68 [30]. Phosphorylation was ascertained by SDS-
PAGE, by MALDI-TOF mass spectrometry performed as described
previously [29], by performing a pilot reaction with 32P-labeled ATP,
and by 31P NMR spectroscopy (Fig. 2). SDS-PAGE was performed with
the Tris-Tricine system [31].
Solution NMR samples were prepared by dissolving pure lyoph-
ilized protein in 300 μL of NMR buffer (20 mM sodium citrate pH 5,
10 mM DTT, 10% D2O, and 500 mM SDS). High purity (N98%) SDS
(obtained from Calbiochem or Cambridge Isotopes Laboratories) was
used for protein puriﬁcation and for the NMR samples.
2.2. NMR experiments and data analysis
The 1H/15N NMR correlation spectra were obtained with the
standard fast HSQC (heteronuclear single quantum coherence)
experiment [32]. Backbone resonances of pFXYD1 and FXYD1(S68D)
were assigned using the three-dimensional 15N-NOESY-HSQC exper-
iment [33] with a NOESY mixing time of 150 ms, and by comparisonFig. 2. PKA phosphorylates FXYD1 at a single site and induces a mobility shift of the
FXYD1 band on SDS-PAGE. (A) Coomassie stained SDS polyacrylamide gel showing
bands for molecular weight standards (lane 1), FXYD1 (lane 2), and pFXYD1 (lane 3).
(B) Visualization of 32P-labeled pFXYD1 by radio imaging. (C) MALDI-TOF spectra of
pFXYD1 and FXYD1. (D) 31P NMR of pFXYD1 in micelles.with the spectrum of FXYD1 which had been previously assigned
[6,27]. For the MnCl2 paramagnetic broadening experiments, the
resonance intensities in the 1H/15N HSQC spectrum of FXYD1(S68D)
were measured with a sample containing 1.8 mM MnCl2. All NMR
experiments were performed at 40 °C on a Bruker AVANCE 600 MHz
spectrometer. Chemical shifts were referenced to the H2O resonance
set to its expected position at 40 °C [34]. 31P NMR spectra were
referenced with phosphoric acid. The NMR data were processed using
NMRPipe [35], and the spectra were assigned and analyzed using
Sparky [36].
Dihedral angles were derived from analysis of the NMR chemical
shifts with the program TALOS [37]. The program uses chemical shifts
and amino acid sequence information to search a database of protein
structures and chemical shifts, and predicts the protein backbone
dihedral angles ϕ and ψ. For α-helices, TALOS predictions are
typically classiﬁed as “good” if all of the 10 best database matches
occur in the phib 0 half of the Ramachandran plot, and at least 9 of
the 10 best matches are in a consistent (within a 35° standard
deviation) ϕ/ψ region. However, if the 10 best matches have mutu-
ally inconsistent values of ϕ and ψ, the results are classiﬁed as
ambiguous, and no dihedral angle prediction is made. Fig. 5B shows
“good” TALOS predictions obtained for FXYD1 and pFXYD1 using only
N and HA chemical shifts, and compares the results to those obtained
for FXYD1 using the previously measured N, HA, CA and CB chemical
shifts [27].
2.3. Computational methods
Calculations to generate a molecular model of the α/β/FXYD1 Na,
K-ATPase complex were performed using XPLOR-NIH [38]. The model
was generated using the NMR structure of FXYD1 (PDB: 2JO1) [27],
which includes all 72 residues of FXYD1, and the crystal structure of
the pig kidney Na,K-ATPase (PDB: 3B8E) [25], which consists of
residues 19–1016 of the 1016-residue α1 subunit, transmembrane
residues 28–73 of the 303-residue β1 subunit, and transmembrane
residues 23–51 of the 66-residue FXYD2a subunit. Missing hydrogens
were added using XPLOR-NIH.
First, the coordinates of FXYD2 in the crystal structure were
replaced with those of FXYD1 by aligning the CA atoms of their
homologous transmembrane helices (FXYD1 residues Gly19-Gly31,
FXYD2 residues G29–G41). The average RMSD between the trans-
membrane CA atoms of the two aligned segments was 1.19 Å.
Second, the resulting coordinates for the α/β/FXYD1 complex
were subjected to 4 stages of Cartesian coordinate Powell mini-
mization, where energy terms for covalent and non bonded inter-
actions were introduced gradually as follows: 100 steps with a term
for covalent bonds (k=1); 500 steps with terms for covalent bonds
and bond angles; 500 steps with terms for covalent bonds, bond
angles and improper dihedral angles; and 500 steps with terms for
covalent bonds, bond angles, improper dihedral angles, andweak non-
bonded van der Waals interactions (kVDW=0.01 kcal mol−1 Å−4;
krad=0.8).
Third, this minimized starting structure was subjected to a high-
temperature semi-rigid body simulated annealing [39], using internal
coordinates dynamics [40], to optimize the interface between FXYD1
and the α subunit. In this step, all the α, β, and FXYD1 atoms were
held ﬁxed, except those of the side chains (from CG onward) of FXYD1
and of the αM9 transmembrane helix (Lys945–Tyr963). These side
chains were allowed both rotational and translational degrees of
freedom. The energy function included terms for covalent geometry,
Van der Waals contacts, and the torsion angle database Rama
potential [41], to select preferred side chain conformations relative
to the backbone dihedral angles. The energy terms were ramped as:
kang=0.4–1.0 kcal mol−1 deg−2; kimp=0.1–1.0 kcal mol−1 deg−2;
kRAMA=0.02–0.2; kVDW=0.002–4.0 kcal mol−1 Å−4; krad=0.4–0.8.
The ﬁnal model consists of nearly the entire α subunit (998 out of
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of 303 residues), and the entire FXYD1 subunit (72 residues).
Compared to the coordinates of the original NMR and crystal
structures deposited in the PDB, the ﬁnal coordinates for α, β, and
FXYD1 have respective average pairwise RMSDs of 0.27 Å, 0.32 Å, and
0.17 Å for the backbone atoms, and of 0.49 Å, 0.46 Å, and 1.74 Å for
non-hydrogen atoms.
Molecular structures were visualized with the program Pymol
[42]. Electrostatic potentials were calculated in units of kT/e, where k
is the Boltzmann constant, T is the absolute temperature, and e is the
proton charge, using the program PDB2PQR [43]. Electrostatic poten-
tials were projected on the solvent accessible surfaces using the
program APBS [44]. XPLOR and PDB2PQR calculations with pFXYD1
were performed after replacing Ser68 with mono-protonated phos-
phoserine, as expected at pH 5.
3. Results and discussion
3.1. Phosphorylation of FXYD1 by PKA
In vitro phosphorylation by PKA caused FXYD1 to migrate at a
slightly higher apparent molecular weight on SDS-PAGE (Fig. 2A).
This effect is likely due to the 80 Da mass increase from the addition
of HPO3, combined with the negative charge of the phosphate group
causing less SDS to bind the protein. The absence of a band at lower
molecular weight indicates that large-scale phosphorylation of
FXYD1 is obtained with nearly 100% efﬁciency, since the size ex-
clusion chromatography step used to isolate pFXYD1 from the enzy-
matic reaction mixture would not be able to separate the phos-
phorylated and non-phosphorylated proteins. Phosphorylation was
also assessed by 32P radio imaging (Fig. 2B) and by mass spec-
trometry, which shows the characteristic 80 Da mass increase within
the ±0.05% range of the experimental error (Fig. 2C). In the NMR
sample, single site phosphorylation was further conﬁrmed by the 31P
NMR spectrum of pFXYD1 in micelles (Fig. 2D), which displays a
single peak at the expected chemical shift frequency for phospho-
serine at pH 5 [45,46].Fig. 3.NMR 1H/15N HSQC spectra of uniformly 15N-labeled FXYD1 (black), pFXYD1 (red) and
spectra of FXYD1 and pFXYD1. (B) Overlapped spectra of pFXYD1 and FXYD1(S68D).3.2. Effects of Ser68 phosphorylation on FXYD1 conformation
To examine the effects of PKA phosphorylation we ﬁrst compared
the 1H/15N HSQC NMR spectra of FXYD1, pFXYD1 and the mutant
FXYD1(S68D). 1H and 15N chemical shifts from protein backbone
amide groups are very sensitive to changes in chemical environment
and in protein conformation and, in other proteins, phosphorylation
has been shown to induce chemical shift changes as large as several
ppm due to electrostatic effects or to minor local conformational
changes in the vicinity of the negatively charged phosphate group
[47–52].
The HSQC spectra of FXYD1, pFXYD1 and FXYD1(S68D) all exhi-
bit excellent frequency dispersion and a single peak for each amide
site (Fig. 3), indicating that both pFXYD1 and FXYD1(S68D) adopt
uniquely folded conformations. Furthermore, the spectrum of
pFXYD1 shows no evidence of peaks from non-phosphorylated
protein, conﬁrming the presence of a single (N90%) phosphorylated
species in the sample. Both the spectra of pFXYD1 and FXYD1(S68D)
exhibit extensive overlap with the spectrum of FXYD1, indicating
that the protein does not undergo a major conformational change
upon either Ser68 phosphorylation or mutation to Asp. Peaks from
residues 1–54, which include the transmembrane domain, are not
perturbed at all and could be assigned to speciﬁc amino acids by
direct comparison with the previously assigned spectrum of FXYD1
[27]. However, peaks from the cytoplasmic helix (h4), which
contains the phosphorylation site, exhibited signiﬁcant changes in
both 1H and 15N chemical shifts. These peaks could not be assigned
by direct comparison and required the use of 1H/15N NOESY-HSQC
experiments.
Maps of the chemical shift changes resulting from phosphorylation
or Asp mutation in the NMR spectra of pFXYD1 and FXYD1(S68D)
show that the perturbation at Ser68 is detected throughout the length
of helix h4 (Fig. 4). To determinewhether the NMR frequency changes
reﬂect a conformational change in this region or the electrostatics
effects of the negatively charged phosphate group, we examined
several key NMR indicators of structure (Fig. 5). The short range NOEs
obtained from a three-dimensional 1H/15N NOESY-HSQC spectrum forFXYD1(S68D) (blue). Residues 59 to 72 including helix h4 are indicated. (A) Overlapped
Fig. 4. Effects of S68 phosphorylation or S68D mutation on 1H/15N HSQC chemical shifts and peak intensities. The helical regions determined in the structure of FXYD1 are shown
at the top. (A, B) Combined change in 1H and 15N chemical shifts (Δδtot=[(ΔδH)2+(ΔδN/5)2]1/2). ΔδN is scaled by 1/5 to account for the 5-fold difference between the
chemical shift dispersions of 15N and 1H. The S68D peak has Δδtot=0.97 ppm. (C, D) Changes in 1H chemical shift for pFXYD1 (ΔδH=δHpFXYD1−δHFXYD1) or FXYD1(S68D)
(ΔδH=δHFXYD1(S68D)−δHFXYD1). (E, F) Changes in 15N chemical shift for pFXYD1 (ΔδN=δNpFXYD1−δNFXYD1) or FXYD1(S68D) (ΔδN=δNFXYD1(S68D)−δNFXYD1). Residue S68D (*)
has ΔδN=4.84 ppm. (G, H) Normalized peak intensities for FXYD1 (black) and pFXYD1 or FXYD1(S68D) (white). Positions that are left blank correspond to Pro or overlapped
resonances.
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both FXYD1 and pFXYD1, indicating the absence of conformational
change in h4 after phosphorylation (Fig. 5A). Furthermore, a
comparative TALOS analysis of the chemical shifts measured for
pFXYD1 and FXYD1 indicates that residues 60 to 70 retain anα-helical
conformation after Ser68 phosphorylation (Fig. 5B). Although this
analysis was limited to HN and HA chemical shifts, all of the helical
regions, including h4, that were previously determined in the
structure of FXYD1, using the complete set of 13C, 15N, and 1H che-
mical shifts plus RDCs and NOEs [6,27], were correctly identiﬁed in
both FXYD1 and pFXYD1.
The paramagnetic electrons in the Mn2+ ion induce distance-
dependent broadening of peaks from protein sites that are solvent-
exposed, without affecting those from sites in the hydrophobic
interior of themicelle. The addition ofMnCl2 to FXYD1(S68D) resulted
in substantial line broadening and disappearance of peaks from
residues in the N- and C-terminal regions and in the ﬂexible linker,
while peaks from the transmembrane region and from helix h4
retained signiﬁcant or full intensity, indicative of strong association
with the hydrophobic micelle. This is similar to our previous
observations for FXYD1 in micelles [27] and to previous observations
for FXYD1 in lipid bilayers [53,54]. The data indicate that the basic L-
shaped arrangement of the protein, with one transmembrane
segment and helix h4 embedded parallel to the micelle/membrane
surface, is not signiﬁcantly perturbed by the presence of a negative
charge at residue 68. Thus, since the protein conformation is not
signiﬁcantly altered, we conclude that the observed frequencychanges in the spectra of pFXYD1 and FXYD1(S68D) must be due to
the introduction of a negative charge at residue 68.
The signiﬁcant downﬁeld shifts (to higher frequency) observed for
the amide resonance of Ser68 after phosphorylation (ΔδH=0.24 ppm;
ΔδN=1.57 ppm), or after mutation to Asp (ΔδH=0.09 ppm;
ΔδN=4.84 ppm), reﬂect a deshielding of the corresponding amide
site from the external magnetic ﬁeld (Fig. 4C–F). The inductive
electron-withdrawing effect of the negatively charged phosphatemay
be expected to inﬂuence the amide hydrogen bonds of residue Ser68,
as well as those of Thr69 and Arg70. Indeed, the 1H frequencies of
these residues are all shifted downﬁeld compared to their positions in
the spectrum of FXYD1 and a similar effect is observed for the 1H
frequencies of Thr69 and Arg70 in the spectrum of FXYD1(S68D). The
frequency changes extend along the length of helix h4, and decrease
in magnitude with increasing spatial distance from residue 68.
Interestingly, the frequency changes follow a general trend with
peaks from amides on the C-terminal side of Ser68 moving downﬁeld,
and peaks from amides N-terminal to Ser68 moving upﬁeld (to lower
frequency). This polarized peak perturbation pattern may reﬂect the
interactions of the negatively charged phosphate or Asp with the
macrodipole of helix h4, affecting the electronic environment
throughout the helix, as previously suggested for the Ser-phosphor-
ylated form of His-containing protein [49].
It is also interesting to note that both Ser68 phosphorylation and
Asp mutation induce very signiﬁcant upﬁeld frequency changes for
the peak of Ser63, a residue that is phosphorylated by PKC. Although
the signiﬁcance of this effect cannot be determined from the present
Fig. 5. Effects of S68 phosphorylation or S68D mutation on the conformation of FXYD1.
(A) Sequential and medium range H-H NOEs measured for FXYD1 (black) and pFXYD1
(white). (B) TALOS analysis using N, HA, CA, and CB chemical shifts of FXYD1 (top), only
N and HA chemical shifts of FXYD1 (middle), or only N and HA chemical shifts of
pFXYD1 (bottom). For each residue only “good” TALOS results with 9 or more matches
to the database having dihedral angles in a consistent region of the Ramachandran plot
are shown (see Materials and methods). The average backbone dihedral angles,
obtained for residues 60–70 in helix h4, are reported in each panel. The helical regions
determined in the structure of FXYD1 are shown at the top. (C) Residual peak intensity
(Ires) measured for FXYD1(S68D) after addition of 1.8 mM MnCl2 (Ires= I+Mn/I-Mn).
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PKC phosphorylation, where PKA phosphorylation at Ser68 primes
helix h4 for subsequent PKC phosphorylation at other sites. This could
be important for regulating the transport of FXYD1 from the ER to the
plasma membrane, as proposed for the NMDA NR1 subunit [12].
Previously, we have used 1H/15 N HSQC peak intensities and
heteronuclear 1H–15N NOEs to characterize the backbone dynamics ofFig. 6. Three types of helix h4 reorientation that could give rise to increased rate of dynam
around the helix long axis. (B) Rotational excursions away from the membrane surface. (C)FXYD1 in micelles [6,27]. Resonance intensities correlate with
resonance line widths, which are excellent indicators of local
backbone dynamics and can be easily measured as peak heights in
the HSQC spectra of proteins. Large-amplitude backbone motions that
are rapid compared to the overall reorientation rate of the protein
reduce the line widths and increase the peak intensities, while lower
intensities are observed for less mobile regions or sites undergoing
chemical exchange in the intermediate range of the μs–ms time scale.
For FXYD1, helices h2 and h3 in the transmembrane region are
rigidly connected and have peaks with similar intensities that plateau
at a minimum value in the membrane interior. In contrast, h1 and h4
are somewhat more dynamic, while residues in the termini and in the
linker between h3 and h4 have peaks with much greater intensities,
reﬂecting much greater local dynamics (Figs. 4G and H, black). PKA
phosphorylation and Ser68Asp mutation both produce a very modest
increase in intensity for peaks from h4 (Fig. 4G and H, white),
consistent with a modest increase in backbone dynamics in this
region of the protein. A change in the orientation of h4 relative to the
diffusion tensor of the protein/micelle assembly could produce line
narrowing effects similar to those observed for pFXYD1 and FXYD1
(S68D). However, the observation of signiﬁcant protection from
Mn2+-induced paramagnetic broadening in h4 indicates that a major
change in the helix orientation away from the micelle/membrane
surface is not the cause of line narrowing in the spectra of pFXYD1 and
FXYD1(S68D).
Our previous NMR studies of FXYD1 indicated that helix h4 could
undergo rotational excursions as large as 40° around its long axis
(Fig. 6A), while maintaining the helix amphiphilic polarity relative to
the micelle surface, with apolar residues facing the micelle lipophilic
interior and polar residues facing the aqueous environment [27]. The
peak intensity proﬁles suggest that this is not dramatically changed by
PKA phosphorylation. However, a slight increase in dynamics after
phosphorylation could reﬂect a slightly increased rate of excursions of
helix h4 away from themicelle/membrane surface into the cytoplasm
(Fig. 6B), or a slightly increased rate of helix reorientation in the plane
of themembrane surface (Fig. 6C). For phospholamban, the analogous
but unrelated regulator of the sarcoplasmic reticulum Ca-ATPase,
phosphorylation at Ser16 and its phosphorylation mimicking muta-
tion to Glu also induce amodest change in protein backbone dynamics
near residue 16 [50,55].
3.3. Implications for the interactions of FXYD1 with the Na,K-ATPase
Taken together, the absence of chemical shift or peak intensity
changes outside helix h4, the polarized pattern of chemical shift
perturbations along the helix length, and the modest increase in h4
backbone dynamics, all indicate that PKA phosphorylation does not
induce major changes in either the backbone conformation orics while maintaining the membrane surface association of helix h4. (A) Reorientation
Reorientation in the plane of the membrane surface viewed from the cytoplasm.
Fig. 7. Structural model of theα/β/FXYD1 Na,K-ATPase complex. FXYD1 (teal), andα β
(gray) transmembrane helices are shown within the solvent-accessible surface of the
complex. Arg and Lys side chains at the cytoplasmic membrane surface are blue.
Occluded Rb+/K+ ions identiﬁed in the crystal structure of kidney Na,K-ATPase are
yellow. The proposed voltage-sensing module is at the end of αM10. CA atoms of
FXYD1 Gly20 and Gly31 and FXYD1 Ser68 phosphate (red) are shown as spheres. The
gray slab represents the membrane thickness.
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at themicelle–water interface appears to be signiﬁcantly perturbed by
phosphorylation. A predisposition for membrane surface association
is indicated by the amphiphilic character of h4 and demonstrated by
the NMR structure of FXYD1 in micelles [27] as well as by solid-state
NMR data in lipid bilayers [53,54]. The MnCl2 broadening proﬁle
observed for FXYD1(S68D) (Fig. 5C) indicates that this arrangement is
unchanged by phosphorylation. It is possible that helix h4 adopts a
different orientation in the presence of the Na,K-ATPase α subunit
from that observed for isolated FXYD1. However, the lack of electron
density for the cytoplasmic domains of FXYD2 in the crystal structure
of pig kidney Na,K-ATPase, and of FXYD10 in the structure of the shark
rectal gland Na,K-ATPase, indicates the absence of a strong structural
interaction between the FXYD cytoplasmic domains and α.
A major phosphorylation-induced conformational change of
FXYD1 was proposed in a recent study measuring ﬂuorescence
energy transfer between two ﬂuorescent proteins, one linked to the
C-terminus of FXYD1 and the other to the N-terminus of α1 [56].
These experiments are complicated by the very large sizes of the
ﬂuorescent proteins (∼30 kDa) compared to the size of FXYD1
(∼8 kDa), and also by the dependence of the Na,K-ATPase and FXYD1
plasmamembrane expression levels on PKA and PKC phosphorylation
[9,14]. However, phosphorylation at more than one of the three sites
(Ser63, Ser69, Thr69) could be required to trigger a conformational
change in FXYD1. Furthermore, a conformational change involving
reorientation of helix h4 in the plane of the micelle/membrane
surface (i.e. around an axis perpendicular to the membrane plane, as
shown in Figs. 6C or 8B)wouldmaintain its amphiphilic polarity at the
membrane surface, and cannot be excluded based on the NMR data
reported in this study.
The NMR data together with a comparison of the calculated surface
electrostatic potentials for FXYD1 and pFXYD1 indicate that the effects
of PKA phosphorylation could be due to the presence of the negative
charged phosphate group at the membrane surface, which could
inﬂuence the interactions of residues in h4 with each other, with α,
and with the membrane phospholipid headgroups. Electrostatic
repulsions between the negatively charged phosphate and the
negatively charged micelle/membrane surface, together with poten-
tial changes in the hydrogen bonding pattern, may be sufﬁcient to
account for a slight increase in conformational dynamics of h4. Since
the Na,K-ATPase is sensitive to membrane potential [57,58], these
combined changes in electrostatics at the membrane surface could
also account for the opposing effects of FXYD1 and pFXYD1 on the
functional properties of the pump.
3.4. Structural model of the α/β/FXYD1 complex
As an initial step toward understanding the association of FXYD1
with the Na,K-ATPase, we generated a model of the α/β/FXYD1
complex by replacing the coordinates of endogenous FXYD2 in the
crystal structure of the pump from pig kidney [25] with those of
FXYD1 determined by NMR [27], and performing molecular dynamics
to optimize the α/FXYD1 interface (Figs. 7, 8A). The crystal structures
indicate an intimate association between the FXYD and αM9
transmembrane helices, mediated by two glycines that are fully
conserved in all FXYD proteins (FXYD1 Gly20 and Gly31). Because
only the side chains of FXYD1 and αM9 were allowed rotational and
translational degrees of freedom during the calculation, the backbone
conformations of the α, β and FXYD1 subunits in the resulting model
are unchanged from those of the starting coordinates, and the
orientation of helix h4 on the membrane surface is the same as that
originally determined by the combination of solid-state NMR in lipid
bilayers and solution NMR in micelles [27,54]. Notably, the resulting
model indicates that the membrane surface orientation of helix h4 is
compatible with the FXYD1/αM9 transmembrane association medi-
ated by Gly20 and Gly31. It is also interesting to note that theorientation of FXYD1 in the model is the same as the orientation that
was determined for isolated FXYD1 in lipid bilayer membranes
[27,54]. This suggests that the structure of isolated FXYD1 is
representative of the Na,K-ATPase-bound structure and that, aside
from the Gly-mediated association with αM9, there could be other
FXYD-speciﬁc factors (e.g. electrostatics) that predispose FXYD1 to
adopt a speciﬁc orientation within the membrane.
The crystal structure of pig kidney Na,K-ATPase highlighted a
highly electropositive region near the cytoplasmic membrane surface
and the Na+/K+ ion binding sites of the α subunit. This region is
composed of Arg and Lys residues located at the cytoplasmic ends of
the α transmembrane helices and in their cytoplasmic connecting
loops, and includes Arg1003, Arg1004 and Arg1005 at the end of
αM10, which were proposed to constitute a voltage-sensing module
[25] analogous to the voltage sensors of potassium channels [59,60].
In the α/β/FXYD1model the membrane surface location of FXYD1 h4
further contributes to this network of positive charges, suggesting
that FXYD1 could inﬂuence Na,K-ATPase ion transport by regulating
the membrane electrostatic potential near the ion binding sites
(Figs. 7, 8A). The introduction of negative charge by phosphorylation
would alter the surface electrostatics in h4 and this could have
profound effects on ion binding and transport by the α subunit.
In FXYD1 and in other FXYD proteins the short helical extension
(h3) of the transmembrane helix (h2) could also contribute to this
effect, due to its highly basic nature and membrane-surface location.
In all the FXYD proteins h3 is encoded by a single exon [6] and its
amino acid sequence varies in its use of Arg and Lys residues. Although
both are positively charged, these residues differ in their ability to
form hydrogen bonds (ArgNLys) and in their charge delocalization
(ArgNLys). Thus, their discrete use among the FXYD family members
could provide a further means of modulating their activities.
Fig. 8. Structural model of the α/β/FXYD1 complex and potential alternative orientation of FXYD1 helix h4. (A) 90° views showing the backbone of FXYD1 (teal), and the solvent
accessible surface ofα/β colored by electrostatic potential, with blue to red color gradation spanning a range of ±15 kT/e from positive to negative potential. FXYD1 helix h4 is in the
conformation determined in the NMR structure and the FXYD1/αM9 interfaced was optimized by molecular dynamics. Arg and Lys side chains in h3 and h4 are in blue. (B)
Alternative conformation of FXYD1 where h4 associates with both the membrane surface and the negatively charged crevice (dashed arrow) leading to the ion binding pocket in
center of α.
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Arg side chains in the KvAP channel voltage sensor are paired with
one or more lipid phosphodiester groups at the membrane-water
interface, dramatically inﬂuencing the local electric ﬁeld. This is
consistent with recent ﬁndings of a negatively charged lipid phos-
phodiester requirement for channel function [61] and provides an
attractive explanation for the voltage sensor mechanism. Similar
requirements for negatively charged phospholipids have been
reported for optimal Na,K-ATPase activity (see [22,62] and references
therein), and Arg residues in FXYD1 h3 and h4 could interact with the
lipid headgroups at the membrane-water interface, to modulate the
membrane electrostatics near the Na/K-ATPase ion binding sites.
Furthermore, in the KvAP simulation small vertical motions of the Arg
guanidinium groups along the direction of the membrane normal are
predicted to produce large transmembrane charge ﬂuctuations.
Similarly, the slightly increased dynamics observed for Ser68
phosphorylation, combined with the addition of a negatively charged
phosphate group, could produce transmembrane charge ﬂuctuations
with profound consequences for Na,K-ATPase ion transport.
Phosphorylation of the Ca-ATPase regulator phospholamban also
induces a small increase in backbone dynamics [50,55]. This is accom-
panied by a partial unwinding [50] or loosening [51] of the cytoplasmic
helix in themonomeric formof the protein,while the pentameric form
is reported to exhibit little evidence of conformational change [55] and
to conserve the α-helical structure around the Ser16 phosphorylation
site [63]. Furthermore, Ser16 phosphorylation does not appear to
affect the membrane surface association of the isolated cytoplasmic
domain of phospholamban [53]. Interestingly, the Ser16 phosphory-
lation site of phospholamban is in a short linker between the trans-
membrane and cytoplasmic helices, and situated near the membrane
surface just like Ser68 in FXYD1. Thus, the modulation of membrane
surface potentialmay be a commonmechanism for the regulation of P-
type ATPases by their accessory proteins.
Finally we note that alternative orientations of h4 that maintain
the helix amphiphilic polarity and its membrane surface association
can be envisioned including one that would place helix h4 near a
negatively charged crevice formed by transmembrane helices αM2,
αM4, and αM6, leading to the ion binding pocket in center of the α
subunit (e.g. Fig. 8B). Acidic residues in this region of α are conserved
to allow the approach of cations but exclude anions through thepump, and reversing the charge at just one of those positions converts
the Na,K-ATPase channel from cation selective to anion selective [64].
The net positive charge of helix h4 and its modulation by
phosphorylation could have a major inﬂuence on the electrostatics
around the α anionic crevice, with potentially important conse-
quences for ion binding. Three-dimensional structure determination
of the FXYD1/Na,K-ATPase complex is essential for understanding the
function of FXYD1 and the role of FXYD1 phosphorylation. The α/β/
FXYD1 structural model and the data presented in this study provide
some initial insights.
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